<- Go home

Added to YB: 2024-03-08

Pitch date: 2024-03-07

BHC [neutral]

Bausch Health Companies Inc.

-26.1%

current return

Author Info

Company Info

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Market Cap

$2.6B

Pitch Price

$9.35

Price Target

12.99 (+88%)

Dividend

N/A

EV/EBITDA

7.35

P/E

26.95

EV/Sales

2.39

Sector

Pharmaceuticals

Category

value

Show full summary:
Fundamentals: Bausch's Terrible Balance Sheet

BHC: Trades at 2.4x 2024 EPS despite double-digit growth, but heavy debt load (~6x market cap) and patent cliff risk justify low multiple. Credit markets imply 40%+ bankruptcy risk by 2027. $4.9B BLCO stake spin-off could drive 40% upside but currently paused due to lawsuit.

Read full article (9 min)